CDMO Tergus cuts the ribbon on Durham plant, latest in a line of companies packing into the emerging NC hub
Among the fastest-growing biotech hubs in the US, North Carolina has seen a flurry of investments from drugmakers, particularly contract manufacturers. Now, another CDMO is planting its flag near the Raleigh-Durham corridor, leveraging the growing brain trust in the area.
This week, Tergus Pharma cut the ribbon on a 100,000-square-foot headquarters and CDMO facility in Durham, NC. The new facility will house four R&D labs, six manufacturing suites and six fill-finish and packaging suites. The company’s goal is lofty: become the largest topical drug CDMO in the US.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.